ESSA Pharma Inc. Common Stock
Symbol: EPIX (NASDAQ)
0.20
▲ (2.62%) 0.005
Company Description:
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
Key Stats
- Today's Open: $0.197
- Today's High: $0.212
- Today's Low: $0.193
- Today's Volume: 126.58K
- Yesterday Close: $0.191
- Yesterday High: $0.2
- Yesterday Low: $0.185
- Yesterday Volume: 5.09M
- Last Min Volume: 883
- Last Min High: $0.196
- Last Min Low: $0.196
- Last Min VWAP: $0.196
Company Profile
- Name: ESSA Pharma Inc. Common Stock
- Website: https://www.essapharma.com
- Listed Date: 2015-03-12
- Location: VANCOUVER, A1
- Market Status: Active
- CIK Number: 0001633932
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $9.04M
- Round Lot: 100
- Outstanding Shares: 47.31M
- Asset Type: CS
RECENT FILINGS FOR EPIX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-30 | DEFA14A | View |
| 2025-09-30 | 8-K | View |
| 2025-09-25 | DEFA14A | View |
| 2025-09-24 | DEFA14A | View |
| 2025-09-24 | DEFA14A | View |
| 2025-09-24 | 8-K | View |
| 2025-09-10 | DEFA14A | View |
| 2025-09-10 | 8-K | View |
| 2025-08-25 | DEFA14A | View |
| 2025-08-25 | 8-K | View |
| 2025-08-14 | DEFA14A | View |
| 2025-08-14 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-11 | DEFM14A | View |
| 2025-08-07 | 4 | View |
| 2025-08-07 | SCHEDULE 13D/A | View |
| 2025-08-06 | DEFA14A | View |
| 2025-08-06 | 8-K | View |
| 2025-07-31 | DEFA14A | View |
| 2025-07-31 | 8-K | View |
Latest News on EPIX